背景:高血压是最重要的心血管疾病危险因素之一,影响着超过1亿美国成年人。与高血压相关的健康不平等现象在黑人社区中普遍存在,因为黑人更有可能使用急诊科(ED)进行与慢性病相关的门诊护理,这与降低血压(BP)控制密切相关,对高血压的认识下降,和不良心血管事件。为了减少高血压相关的健康差异,我们开发了MI-BP,一种文化定制的多行为移动健康干预措施,以BP自我监测的行为为目标,身体活动,钠摄入量,从ED和社区环境中招募的高血压不受控制的黑人个体的药物依从性。
目的:我们试图确定MI-BP对血压的影响以及身体活动的次要结局,钠摄入量,药物依从性,与1年随访时加强常规护理控制相比,血压控制。
方法:我们进行了为期1年的,2组MI-BP干预的随机对照试验与增强的常规护理对照组相比,其中25至70岁的参与者接受了BP袖带和高血压相关的教育材料。参与者是从底特律的ED和其他社区环境中招募的,密歇根州,在那里他们被筛选为初始资格和登记。纳入后约2周和4周进行基线数据收集和随机分组,以确保参与者患有不受控制的高血压并愿意参加。数据收集访问发生在13、26、39和52周。感兴趣的结果包括BP(主要结果)和身体活动,钠摄入量,药物依从性,和血压控制(次要结果)。
结果:我们获得了869名参与者的同意并纳入了这项研究,但最终将162名(18.6%)参与者随机分组。在1年,与基线相比,两组均显示收缩压显着降低(MI-BP组:平均收缩压降低22.5mmHg,P<.001;对照组:24.1mmHg降低,P<.001),两组之间没有显着差异(时间-手臂相互作用:P=.99)。两组均有改善,但两组间均未发现舒张压的差异,身体活动,钠摄入量,药物依从性,和BP控制。两组均观察到较大的辍学率(约60%)。
结论:总体而言,随机接受强化常规治疗控制和MI-BP治疗的参与者在BP和其他结局方面均有显著改善;没有检测到组间的差异,谈到积极外展和参与的一般好处,重点是降低城市居民的心脏代谢风险,社会经济地位低的黑人人口。发现了高辍学率,并且在与类似人群一起工作时可能是预期的。未来的工作需要更好地了解与移动健康干预措施的参与,尤其是在这个群体中。
背景:ClinicalTrials.govNCT02955537;https://clinicaltrials.gov/study/NCT02955537。
■RR2-10.2196/12601。
BACKGROUND: Hypertension is one of the most important cardiovascular disease risk factors and affects >100 million American adults. Hypertension-related health inequities are abundant in Black communities as Black individuals are more likely to use the emergency department (ED) for chronic disease-related ambulatory care, which is strongly linked to lower blood pressure (BP) control, diminished awareness of hypertension, and adverse cardiovascular events. To reduce hypertension-related health disparities, we developed MI-BP, a culturally tailored multibehavior mobile health intervention that targeted behaviors of BP self-monitoring, physical activity, sodium intake, and medication adherence in Black individuals with uncontrolled hypertension recruited from ED and community-based settings.
OBJECTIVE: We sought to determine the effect of MI-BP on BP as well as secondary outcomes of physical activity, sodium intake, medication adherence, and BP control compared to enhanced usual care control at 1-year follow-up.
METHODS: We conducted a 1-year, 2-group randomized controlled
trial of the MI-BP intervention compared to an enhanced usual care control group where participants aged 25 to 70 years received a BP cuff and hypertension-related educational materials. Participants were recruited from EDs and other community-based settings in Detroit, Michigan, where they were screened for initial eligibility and enrolled. Baseline data collection and randomization occurred approximately 2 and 4 weeks after enrollment to ensure that participants had uncontrolled hypertension and were willing to take part. Data collection visits occurred at 13, 26, 39, and 52 weeks. Outcomes of interest included BP (primary outcome) and physical activity, sodium intake, medication adherence, and BP control (secondary outcomes).
RESULTS: We obtained consent from and enrolled 869 participants in this
study yet ultimately randomized 162 (18.6%) participants. At 1 year, compared to the baseline, both groups showed significant decreases in systolic BP (MI-BP group: 22.5 mm Hg decrease in average systolic BP and P<.001; control group: 24.1 mm Hg decrease and P<.001) adjusted for age and sex, with no significant differences between the groups (time-by-arm interaction: P=.99). Similar patterns where improvements were noted in both groups yet no differences were found between the groups were observed for diastolic BP, physical activity, sodium intake, medication adherence, and BP control. Large dropout rates were observed in both groups (approximately 60%).
CONCLUSIONS: Overall, participants randomized to both the enhanced usual care control and MI-BP conditions experienced significant improvements in BP and other outcomes; however, differences between groups were not detected, speaking to the general benefit of proactive outreach and engagement focused on cardiometabolic risk reduction in urban-dwelling, low-socioeconomic-status Black populations. High dropout rates were found and are likely to be expected when working with similar populations. Future work is needed to better understand engagement with mobile health interventions, particularly in this population.
BACKGROUND: ClinicalTrials.gov NCT02955537; https://clinicaltrials.gov/
study/NCT02955537.
UNASSIGNED: RR2-10.2196/12601.